Aevi Genomic Medicine, Inc.
(NASDAQ : GNMX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.57%190.451.2%$558.00m
GILDGilead Sciences, Inc.
-0.35%70.670.9%$494.00m
BIIBBiogen Inc.
-1.47%314.391.3%$441.96m
CELGCelgene Corporation
-0.88%69.621.2%$414.72m
ILMNIllumina, Inc.
-1.14%307.633.5%$393.75m
REGNRegeneron Pharmaceuticals, Inc.
-1.56%336.772.6%$277.39m
VRTXVertex Pharmaceuticals Incorporated
-3.79%163.851.9%$261.05m
ALXNAlexion Pharmaceuticals, Inc.
-1.86%116.322.0%$195.38m
AAgilent Technologies, Inc.
-1.21%63.561.5%$166.10m
EXASExact Sciences Corporation
-1.79%68.1725.3%$146.98m
LGNDLigand Pharmaceuticals Incorporated
-0.42%147.8023.3%$143.00m
SRPTSarepta Therapeutics, Inc.
-4.98%110.9516.4%$126.92m
ECYTEndocyte, Inc.
-0.09%23.562.0%$120.16m
INCYIncyte Corporation
-0.21%63.602.5%$112.16m
NKTRNektar Therapeutics
1.66%37.975.6%$107.61m

Company Profile

Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engages in finding treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded on January 27, 2000 and is headquartered in Wayne, PA.